Reference
Fenchel K, et al. Single center experience with Abemaciclib Administration in unfavourable relapsed breast cancer patients with progression after Palbociclib. Oncology Research and Treatment 43 (Suppl. 4): 165-166 abstr. 689, Oct 2020. Available from: URL: http://doi.org/10.1159/000510995 [abstract]
Rights and permissions
About this article
Cite this article
Abemaciclib/palbociclib. Reactions Weekly 1943, 15 (2023). https://doi.org/10.1007/s40278-023-32900-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-32900-2